Sandra Kraemer

9PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Fluid-structure interaction and aeroacousticsPredictive and prognostic markersRespiratory diseasesCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 27, 2025
Fibroblast Growth Factor 23 Is a Strong Predictor of Adverse Events After Left Ventricular Assist Device Implantation.

Wissam Yared, Leyla Dogan, Ahsannullah Madad Fassli

|Aug 12, 2023
A Potential Association between Ribonuclease 1 Dynamics in the Blood and the Outcome in COVID-19 Patients.

Elisabeth Zechendorf, Christian Beckers, Nadine Frank

|Dec 23, 2022
DAMPs Released from Proinflammatory Macrophages Induce Inflammation in Cardiomyocytes via Activation of TLR4 and TNFR.

Carolina Neu, Yvonne Thiele, Fabienne Horr

|Sep 23, 2022
The Potential Impact of Heparanase Activity and Endothelial Damage in COVID-19 Disease.

Elisabeth Zechendorf, Katharina Schröder, Lara Stiehler

|Jun 24, 2022
Comparison of the Hemocompatibility of an Axial and a Centrifugal Left Ventricular Assist Device in an In Vitro Test Circuit.

Patrick Borchers, Patrick Winnersbach, Sandra Kraemer

Pageof 2